vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and InMode Ltd. (INMD). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $93.2K, roughly 201.6× InMode Ltd.). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs 23.5%, a 35.5% gap on every dollar of revenue.

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

Mode Media, Inc., was a digital lifestyle media company operating a suite of websites where content was produced by anyone but reviewed by professional editors prior to publishing. In 2013, Mode Media had a valuation of about $1 billion as the company prepped for an IPO. In 2015, Mode Media had grown to over $100 million in revenue, primarily from providing native content, branded video and digital advertising to large brands but had over $100 million in expenses.

BLFS vs INMD — Head-to-Head

Bigger by revenue
BLFS
BLFS
201.6× larger
BLFS
$18.8M
$93.2K
INMD
Higher net margin
BLFS
BLFS
35.5% more per $
BLFS
58.9%
23.5%
INMD

Income Statement — Q4 2025 vs Q3 2025

Metric
BLFS
BLFS
INMD
INMD
Revenue
$18.8M
$93.2K
Net Profit
$11.1M
$21.9K
Gross Margin
77.6%
Operating Margin
7.2%
Net Margin
58.9%
23.5%
Revenue YoY
24.3%
Net Profit YoY
-11.1%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
INMD
INMD
Q4 25
$18.8M
Q3 25
$28.1M
$93.2K
Q2 25
$25.4M
$95.6K
Q1 25
$23.9M
$77.9K
Q4 24
$15.1M
Q3 24
$21.4M
$130.2K
Q2 24
$19.7M
$86.4K
Q1 24
$18.4M
$80.3K
Net Profit
BLFS
BLFS
INMD
INMD
Q4 25
$11.1M
Q3 25
$621.0K
$21.9K
Q2 25
$-15.8M
$26.7K
Q1 25
$-448.0K
$18.2K
Q4 24
$12.5M
Q3 24
$-1.7M
$51.0K
Q2 24
$-20.7M
$23.8K
Q1 24
$-10.2M
$23.7K
Gross Margin
BLFS
BLFS
INMD
INMD
Q4 25
Q3 25
77.6%
Q2 25
80.0%
Q1 25
78.2%
Q4 24
Q3 24
81.5%
Q2 24
80.2%
Q1 24
79.6%
Operating Margin
BLFS
BLFS
INMD
INMD
Q4 25
7.2%
Q3 25
-0.3%
Q2 25
-65.5%
Q1 25
-5.1%
Q4 24
3.6%
Q3 24
-2.0%
Q2 24
-6.6%
Q1 24
-17.9%
Net Margin
BLFS
BLFS
INMD
INMD
Q4 25
58.9%
Q3 25
2.2%
23.5%
Q2 25
-62.3%
28.0%
Q1 25
-1.9%
23.4%
Q4 24
82.5%
Q3 24
-8.0%
39.2%
Q2 24
-105.1%
27.6%
Q1 24
-55.4%
29.5%
EPS (diluted)
BLFS
BLFS
INMD
INMD
Q4 25
$0.23
Q3 25
$0.01
Q2 25
$-0.33
Q1 25
$-0.01
Q4 24
$0.27
Q3 24
$-0.04
Q2 24
$-0.45
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
INMD
INMD
Cash + ST InvestmentsLiquidity on hand
$33.0M
$155.3K
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$371.9M
$703.8K
Total Assets
$405.9M
$785.7K
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
INMD
INMD
Q4 25
$33.0M
Q3 25
$29.5M
$155.3K
Q2 25
$31.9M
$155.3K
Q1 25
$66.9M
$155.3K
Q4 24
$91.5M
Q3 24
$24.0M
$144.4K
Q2 24
$22.0M
$144.4K
Q1 24
$29.7M
$144.4K
Total Debt
BLFS
BLFS
INMD
INMD
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
BLFS
BLFS
INMD
INMD
Q4 25
$371.9M
Q3 25
$353.7M
$703.8K
Q2 25
$347.2M
$703.8K
Q1 25
$352.6M
$703.8K
Q4 24
$348.9M
Q3 24
$325.5M
$787.4K
Q2 24
$321.4M
$787.4K
Q1 24
$333.4M
$787.4K
Total Assets
BLFS
BLFS
INMD
INMD
Q4 25
$405.9M
Q3 25
$392.1M
$785.7K
Q2 25
$387.2M
$785.7K
Q1 25
$395.1M
$785.7K
Q4 24
$399.5M
Q3 24
$381.7M
$863.3K
Q2 24
$375.0M
$863.3K
Q1 24
$401.6M
$863.3K
Debt / Equity
BLFS
BLFS
INMD
INMD
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
INMD
INMD
Operating Cash FlowLast quarter
$4.9M
$24.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.44×
1.12×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
INMD
INMD
Q4 25
$4.9M
Q3 25
$6.1M
$24.5K
Q2 25
$7.4M
$24.1K
Q1 25
$1.7M
$14.0K
Q4 24
$1.6M
Q3 24
$4.8M
$34.0K
Q2 24
$6.5M
$42.1K
Q1 24
$-4.5M
$24.1K
Cash Conversion
BLFS
BLFS
INMD
INMD
Q4 25
0.44×
Q3 25
9.83×
1.12×
Q2 25
0.90×
Q1 25
0.77×
Q4 24
0.13×
Q3 24
0.67×
Q2 24
1.77×
Q1 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons